Filter Results:
(1,132)
Show Results For
- All HBS Web
(1,132)
- People (3)
- News (201)
- Research (685)
- Events (5)
- Multimedia (7)
- Faculty Publications (325)
Show Results For
- All HBS Web
(1,132)
- People (3)
- News (201)
- Research (685)
- Events (5)
- Multimedia (7)
- Faculty Publications (325)
- Web
FAQs - Institute For Strategy And Competitiveness
HBS ISC About the Institute About the Institute Contact Us Faculty & Staff Institute Associates Ludcke FAQs FAQs FAQs What is the Institute for Strategy & Competitiveness, and what does it do? The Institute for Strategy and Competitiveness (ISC) is a nonprofit... View Details
- Web
What Others Are Saying - Institute For Strategy And Competitiveness
would if the medical marketplace even remotely resembled an efficient, competitive market.” — John C. Goodman, Ph.D., President, National Center for Policy Analysis “Redefining Health Care has the makings of... View Details
- 01 Mar 2007
- News
Daniel Vasella
the test as he methodically refashioned the two old-line chemical companies with disparate corporate cultures into a single entity focused on health care and powered by an innovative approach to R&D. Today, Novartis is one of the world’s... View Details
- Web
1.12 Clearance for Return | MBA
1.12 Clearance for Return 1.0 Academic Information & Policies After a hospitalization or emergency room visit by one of its students that raises serious concerns about the student’s health or well-being, or... View Details
- January 2007 (Revised January 2007)
- Background Note
Note on the U.S. Food and Drug Administration
By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details
Keywords: Health; Governance Compliance; Policy; Product Development; Government and Politics; Pharmaceutical Industry; Medical Devices and Supplies Industry; Biotechnology Industry; Public Administration Industry; United States
Higgins, Robert F., Richard G. Hamermesh, and Virginia Fuller. "Note on the U.S. Food and Drug Administration." Harvard Business School Background Note 807-050, January 2007. (Revised January 2007.)
- Portrait Project
Sally Aaron
who lack access to life-saving and life-changing technologies, or the billions in the world who lack access to even basic care, I want to be a part of the solution to this problem by working with policy and public View Details
- Web
Esther Koh | MBA
Esther Koh Bioengineering (SB), Secondary in Global Health & Health Policy Kirkland 2022 Cohort 3 Bridging experiments in the lab with commercialization strategies in industry... View Details
- 01 Dec 2011
- News
Donor Spotlight
Penny and Bill George Investing in HBS What Keeps HBS Ahead? You Do! The Personal Touch Research With Impact: Changing Global Health Practices FAQ Penny and Bill George (MBA ’66) Bill and Penny George’s generous $1.25 million 45th Reunion... View Details
- 05 Jan 2017
- News
Seven HBS Alumni Make Forbes 30 Under 30
Under 30 entry VENTURE CAPITAL Nimi Katragadda (MBA 2015) Principal, BoxGroup 30 Under 30 entry Michael Ma (MBA 2015) General Partner, Liquid 2 Ventures 30 Under 30 entry Caitlin Strandberg (MBA 2016) Vice President, FirstMark 30 Under 30 entry View Details
- Profile
Vivek Garg
Right out of college, Vivek Garg was directly exposed to difficult health-care policy issues. As part of Congress's Medicare Payment Advisory Council (MPAC), Vivek reviewed the coordination of policies and... View Details
- Web
1.19 Immersive Field Courses (IFC) | MBA
are responsible for confirming the details of their personal international health insurance coverage, which includes verifying the details of benefits, the claims submission process, and potential out-of-pocket costs while traveling.... View Details
- 10 Aug 2020
- Research & Ideas
COVID's Surprising Toll on Careers of Women Scientists
or is not allowing you to come onto campus does not seem to make a difference on what the scientists are reporting,” Myers says. “It’s not really about a policy of whether you can go into campus per se. It's whether your postdocs are... View Details
- Web
1.18 Field Global Capstone | MBA
their personal international health insurance coverage, which includes verifying the details of benefits, the claims submission process, and potential out-of-pocket costs while traveling. Photography/Videography View Details
- Web
2021 Symposium - Race, Gender & Equity
Gender and Work Research Symposium: Virtual Edition Gender and Work Research Symposium: Virtual Edition 6 MAY 2021 Home Speakers Videos Agenda Danielle Allen Danielle Allen is James Bryant Conant University Professor at Harvard University. She is a political... View Details
- Web
Online Harassment | About
“intense personal harassment” under the University-wide Statement on Rights and Responsibilities (USRR) and “bullying” under the Non-Discrimination and Anti-Bullying Policies (NDAB) . Doxing occurs under these View Details
- November 2021
- Article
A Salient Sugar Tax Decreases Sugary Drink Buying
By: Grant E. Donnelly, Paige Guge, Ryan Howell and Leslie John
Many governments have introduced sugary drink excise taxes to reduce purchasing and consumption of such drinks; however, they do not typically stipulate how such taxes should be communicated at point-of-purchase. Historical, field, and experimental data entailing over... View Details
Keywords: Decision-making; Open Data; Open Materials; Preregistered; Health; Policy; Taxation; Consumer Behavior; Decision Making
Donnelly, Grant E., Paige Guge, Ryan Howell, and Leslie John. "A Salient Sugar Tax Decreases Sugary Drink Buying." Psychological Science 32, no. 11 (November 2021): 1830–1841.
- 25 Jun 2020
- News
Global Centers Broaden Understanding of Business and the Pandemic
details on the unfolding of the pandemic and the policies implemented to manage the outbreak in 19 European countries and the EU. The center also co-authored a library case study, “COVID-19: Tracing the Virus in Europe and Italy”, focused... View Details
- 15 Dec 2020
- Research & Ideas
The Unspoken Messages of COVID-19 Restrictions
Soaring COVID-19 cases are forcing government officials to confront a critical question: Should they lock down the economy further? Whether to curb activities like indoor dining might seem like a simple choice, but the decision to ease restrictions can send a powerful... View Details
- 27 Apr 2021
- Research & Ideas
New Research: Surviving Bankruptcy, Useful Economics, and Retirement
This focus, I argue, limits the practical utility of the discipline because universal propositions form only a part of new policy recipes.” Remote Patient Monitoring—Overdue or Overused? New England Journal of Medicine Keizra Mecklai,... View Details
- 14 Mar 2019
- News
The Merchant of Osaka
population is increasing faster than any other nation in history, while its birthrate is shrinking. That double whammy is reducing both the workforce to care for the elderly and the tax base to support its universal health insurance... View Details
Keywords: Health, Social Assistance